Docetaxel
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21979 publications
Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes.
Journal: The Journal of urology
Published: June 22, 2026
In Vivo Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.
Journal: Cancer investigation
Published: June 21, 2026
Development and evaluation of docetaxel-hesperidin loaded nanoformulation for the treatment of breast cancer.
Journal: Journal of biomaterials science. Polymer edition
Published: June 20, 2026
Rucaparib - drug evaluation: a PARP inhibitor for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer.
Journal: Future oncology (London, England)
Published: June 18, 2026
Design, Synthesis, and Evaluation of Antitumor Activity of Novel Phenylahistin Derivatives with Double F-Substitution via Dual Inhibition of Microtubule and P53/BCL-2/BAX Signaling Pathways.
Journal: Journal of medicinal chemistry
Published: June 11, 2026
Real-world comparison of androgen receptor pathway ınhibitors versus docetaxel as first-line treatment in metastatic hormone-sensitive prostate cancer.
Journal: Current medical research and opinion
Published: June 08, 2026
Effect of taxane-based adjuvant chemotherapy on breast cancer-related lymphedema: A propensity score matching study.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: June 05, 2026
A Novel Patient-Derived Xenograft Model of Inflammatory Breast Cancer.
Journal: Research square
Published: June 04, 2026
Application of small interfering RNAs and drug combination for pancreatic cancer therapy.
Journal: Journal of drug targeting
Published: May 31, 2026
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer (ARETTA).
Journal: JCO global oncology
Published: May 29, 2026
Inhibition of the cGAS-STING pathway mitigates liver injury induced by docetaxel-carboplatin neoadjuvant chemotherapy via autophagy promotion.
Journal: Acta biochimica et biophysica Sinica
Published: May 29, 2026
Directly comparing randomized and real-world controls in adjuvant breast cancer.
Journal: Journal of comparative effectiveness research
Published: May 29, 2026
Last Updated: 06/30/2026